Program Description
Diabetes is an extremely common condition worldwide, with 537 million individuals affected in 2021, which is currently on the rise. Patients with either type 1 or type 2 diabetes utilize insulin to manage their blood sugar, of which insulin pump therapy is a notable advancement in treatment technology. Insulin pump therapy can continuously infuse insulin at the proper rate to minimize adverse safety risks like hypoglycemia. While advancements in diabetes technology can improve outcomes, both providers and patients may find them difficult to implement. Insulin pump technology is rapidly progressing, which can make it overwhelming to assess the benefits and who should use them. Pharmacists can help address barriers such as complexity, patient access, and a general lack of knowledge about the technology through training and increasing awareness. This activity will cover the role of technology in managing diabetes, evaluating current and emerging insulin pump therapies and patient-specific strategies to facilitate the uptake of this technology. With a thorough understanding of novel insulin pump therapies, pharmacists can better utilize them for treatment, which can help improve quality of life and reduce diabetes’ burden.
Target audience: Pharmacy technicians
Type of activity: Application
Release date: October 30, 2024
Expiration date: October 30, 2025
Time to complete activity: 1.0 hour
Learner level: Foundational
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Explain the role of technology in managing diabetes
- Identify current and emerging insulin pump therapies based on clinical data and guideline recommendations
- Examine patient-specific strategies to facilitate the uptake of novel diabetes technologies in eligible patients
Gregory Castelli, PharmD, FCCP, BCPS, BC-ADM, CDCES
Associate Professor, Director of Academic and Clinical Pharmacy
Department of Family Medicine
University of Pittsburgh School of Medicine
Co-Lead, Interprofessional Thread
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity numbers 0290-0000-24-312-H01-P and 0290-0000-24-312-H01-T. The activity is available for CE credit through October 30, 2025.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty
Gregory Castelli, PharmD, FCCP, BCPS, BC-ADM, CDCES
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Dipti Desai, PharmD, MBA, CHCP; Crissy Wilson; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green have no relevant financial relationships with commercial interests to disclose.
An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms